Skip to main content
Clinical Trials/CTRI/2017/09/009696
CTRI/2017/09/009696
Completed
Phase 2

A Randomised Control Trial to Compare the effect of Single dose Platelet Rich Plasma and Corticosteroid Injection in patients with Carpal tunnel syndrome

Department of PMR0 sites84 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Carpal Tunnel syndromeHealth Condition 2: G560- Carpal tunnel syndrome
Sponsor
Department of PMR
Enrollment
84
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 28, 2018
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of PMR

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinically diagnosed cases of Carpal Tunnel Syndrome
  • 2\. Failure of conservative management for 4 weeks

Exclusion Criteria

  • 1\.Local skin infection at the site of injection
  • 2\.Diagnosed cases of platelet dysfunction and Thrombocytopenia (Platelet \<1\.5 lakhs)
  • 3\.Diagnosed cases of Malignancy
  • 4\.Uncontrolled endocrine dysfunction (Type 2 Diabetes mellitus (FBS \>110mg/dl, PPBS \>140mg/dl), Hypothyroidism ( \>3\.3mIU/L) )
  • Hb \< 10 gm%
  • 5\.Severe CTS with thenar muscle atrophy (Mackinnsonââ?¬•s classification)
  • 6\.Diagnosed cases of rheumatoid arthritis
  • 7\.Prior surgery or fracture in the same wrist
  • 8\.Prior steroid injection in the same wrist within 6 months of the study
  • 9\.Patient on anticoagulant therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials